Gilead Sciences reported $6.94B in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acorda Therapeutics ACOR:US USD 20.7M 2.43M
Agios Pharmaceuticals AGIO:US USD 122.45M 33.91M
ALKERMES ALKS:US USD 263.96M 9.31M
Alnylam Pharmaceuticals ALNY:US USD 1.07B 497.67M
Amgen AMGN:US USD 9.5B 4.3B
Biogen BIIB:US USD 3.68B 1.03B
Biomarin Pharmaceutical BMRN:US USD 761.52M 141.71M
Bluebird Bio BLUE:US USD 66.48M 15.02M
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Coherus Biosciences CHRS:US USD 286.8M 11.32M
Eli Lilly And LLY:US USD 2.62B 5.5M
Gilead Sciences GILD:US USD 6.94B 2.2B
Glaxosmithkline GSK:US GBP 3.61B 2.86B
GlaxoSmithKline GSK:LN GBP 3.61B 2.86B
Intercept Pharmaceuticals ICPT:US USD 113.2M 55.18M
Johnson & Johnson JNJ:US USD 1.52B 452M
Moderna Inc MRNA:US USD 3.03B 154M
Neurocrine Biosciences NBIX:US USD 212.2M 48.9M
Novartis NOVN:VX USD 8.73B 5.1B
Ptc Therapeutics PTCT:US USD 104.42M 53.73M
Puma Biotechnology PBYI:US USD 77.96M 25.2M
Regeneron Pharmaceuticals REGN:US USD 3.49B 96.2M
Sangamo Biosciences SGMO:US USD 94.57M 23.14M
Sarepta Therapeutics SRPT:US USD 1.04B 170.06M
Teva Pharmaceutical Industries TEVA:US USD 2.22B 167M
United Therapeutics UTHR:US USD 966.8M 171.6M
Vertex Pharmaceuticals VRTX:US USD 9.17B 469.3M
YTE INCY:US USD 2.69B 255.24M